Skip to main content
Jinyu Bio-Technology Co.,Ltd. logo

Jinyu Bio-Technology Co.,Ltd. — Investor Relations & Filings

Ticker · 600201 ISIN · CNE000000Y37 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 1,777 across all filing types
Latest filing 2020-01-03 Capital/Financing Update
Country CN China
Listing Shanghai Stock Exchange 600201

About Jinyu Bio-Technology Co.,Ltd.

http://jinyubiotech.com/

Jinyu Bio-Technology Co., Ltd. focuses on the research, development, and manufacturing of veterinary biological products and pharmaceuticals. The company is a prominent supplier of animal vaccines, particularly specializing in Foot-and-Mouth Disease (FMD) vaccines, brucellosis vaccines, and solutions for swine and poultry diseases. It utilizes advanced biotechnology platforms, including large-scale suspension culture and high-efficiency purification processes, to produce high-titer, high-purity biologicals. The organization operates sophisticated research facilities and Biosafety Level 3 (P3) laboratories to support the development of diagnostic reagents and preventive treatments. Its operations center on enhancing animal health through scientific innovation, providing comprehensive disease control strategies for the global livestock industry and large-scale agricultural operations.

Recent filings

Filing Released Lang Actions
东北证券股份有限公司关于金宇生物技术股份有限公司非公开发行股票2019年度持续督导工作现场检查报告
Capital/Financing Update Classification · 95% confidence The document is a '现场检查报告' (on-site inspection report) by a sponsoring institution (东北证券股份有限公司) regarding the continuous supervision of a company's non-public stock issuance in 2019. It details the inspection of the use of raised funds, compliance with regulations, and concludes no violations were found. The document is not a full annual report, audit report, or financial statement, but rather a regulatory compliance and supervision report related to capital raising activities. It is not a brief announcement or a proxy statement, but a formal report on the supervision work. This fits best under 'Capital/Financing Update (CAP)' as it relates to updates on fundraising and capital use compliance.
2020-01-03 Chinese
关于使用闲置自有资金进行现金管理的进展公告
Capital/Financing Update Classification · 95% confidence The document is a detailed announcement from a company about its use of idle funds for cash management through entrusted financial products. It includes specifics about the entrusted financial products, the investment amounts, risk control measures, the decision-making process, and independent director opinions. It is not a full financial report like an Annual Report (10-K) or Interim Report (IR), nor is it a brief announcement of voting results or a regulatory filing. The document is a formal announcement about capital management activities, specifically about the company's financing and investment activities with its own funds. Therefore, it fits best under the category of Capital/Financing Update (CAP). The document length and detail support this classification with high confidence.
2019-12-19 Chinese
关于以集中竞价交易方式回购股份的进展公告
Transaction in Own Shares Classification · 100% confidence The document is a progress announcement regarding the company's share repurchase (buyback) activity. It details the number of shares repurchased, the price range, total amount spent, and references previous related announcements. It does not contain financial statements or detailed financial analysis but is an update on capital activity. This fits the definition of a Transaction in Own Shares (POS) filing, which reports on the company's buyback or sale of its own shares.
2019-12-02 Chinese
关于变更办公地址及联系方式的公告
Regulatory Filings Classification · 95% confidence The document is a short announcement regarding the change of the company's office address and contact information. It does not contain financial data, management changes, voting results, or any report publication. It is a regulatory announcement about administrative details. The document length is only 524 characters, indicating it is a brief notice. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2019-11-29 Chinese
关于使用闲置自有资金进行现金管理的进展公告
Capital/Financing Update Classification · 95% confidence The document is a detailed announcement from a company about its use of idle funds for cash management through entrusted financial products. It includes specifics about the financial product, contract terms, risk control, impact on the company, recent financial data, and independent director opinions. It is not a full financial report like an Annual Report (10-K) or Interim Report (IR), nor is it a simple announcement of a report publication. It is also not related to board changes, earnings releases, or legal proceedings. The content fits the category of a Capital/Financing Update (CAP) because it provides an update on the company's financing activities and capital management through investment in financial products. The document length and detail support this classification with high confidence.
2019-11-22 Chinese
关于以集中竞价交易方式回购股份的进展公告
Transaction in Own Shares Classification · 100% confidence The document is a progress announcement regarding the company's share repurchase via centralized bidding transactions. It provides details on the number of shares repurchased, the price range, and total amount spent. It references previous announcements and reports related to the share buyback but does not contain financial statements or detailed financial analysis. The document is relatively short (822 characters) and serves as an update on the share repurchase activity. Therefore, it fits the category of a Transaction in Own Shares (POS) filing, which covers reports of the company buying back its own shares.
2019-11-04 Chinese

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.